Cross-sectional and longitudinal assessment of patient-reported outcome according to treatment options in patients with asymptomatic papillary thyroid microcarcinoma

Cross-sectional and longitudinal assessment of patient-reported outcome according to treatment options in patients with asymptomatic papillary thyroid microcarcinoma - PRO/PTMC

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037962

Enrollment

550

Registered

2019-10-01

Start date

2019-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Papillary thyroid carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with very low-risk papillary thyroid microcarcinoma (cT1aN0M0) diagnosed by ultrasonography and fine needle aspiration biopsy

Exclusion criteria

Exclusion criteria: Patients younger than 18 years old.

Design outcomes

Primary

Measure	Time frame
Patient-reported outcome cross-sectionally assessed by SF-36 and STAI for patients with asymptomatic papillary thyroid carcinoma (cT1aN0M0) who have already underwent active surveillance, immediate conventional surgery and immediate endoscopic surgery since 1995.	—

Secondary

Measure	Time frame
Longitudinal patient-reported outcome prospectively assessed by SF-36 and STAI for patients with asymptomatic papillary thyroid carcinoma (cT1aN0M0) who start to undergo active surveillance, immediate conventional surgery and immediate endoscopic surgery from now on.	—

Countries

Japan

Contacts

Public ContactIwao Sugitani, MD, PhD (Endocrine Surgery)

Nippon Medical School Department of Endocrine Surgery

isugitani@nms.ac.jp0338222131

Outcome results